Germany
Differential Bio, founded in 2024 and headquartered in Germany, is making strides in the bioprocess industry with its Virtual Scale-up Platform for Bioprocess Optimization. The company focuses on enhancing biomass and precision fermentation using integrated AI-modeling, a cutting-edge approach to optimize microbial growth and production processes.
By refining bioprocesses and growth conditions, Differential Bio offers R&D efficiency improvements and significant enhancements in bioproduction yields, cost efficiency, and product quality. This innovative approach positions the company as a key player in industrial biotechnology transformation.
Recently, Differential Bio secured a €2.00M seed investment in March 2025. Notable investors include Ananda Impact Ventures, Better Ventures, Climate Capital, Carbon13, ReGen Ventures, and CDTM Venture Fund. Such strong financial backing underscores investor confidence in Differential Bio's potential to revolutionize the industry.
